PROS1 and COVID-19: For example, a particular SARS-CoV-2 mutation (a novel m6 A methylation loci in the S protein of SARS-CoV-2) was recently shown to increase the risks of developing gastrointestinal (GI) symptoms in COVID-19 patients [50].